Biotech

All Articles

Metsera coordinate with Amneal to lock down GLP-1 supply

.Along with very early stage 1 data today out in bush, metabolic health condition outfit Metsera is ...

Rivus blog posts data to support muscle-sparing weight problems medication claims

.Rivus Pharmaceuticals has actually unveiled the information responsible for its period 2 obesity su...

BMS pays $110M to form T-cell treatment pact, assisting Perfect acquire time to develop prioritized pipe

.Bristol Myers Squibb is actually paying out Excellent Medication $110 thousand in advance to create...

Generate increases an additional $1B-plus Significant Pharma relationship

.Novartis has actually tattooed a bargain potentially worth greater than $1 billion with Flagship-fo...

Metsera GLP-1 information cut exposes 7.5% fat loss at 36 days

.Recently debuted Metsera is actually unfolding some phase 1 record for its GLP-1 receptor agonist, ...

Flagship hopes biotechs group to Mirai to improve hereditary meds

.In the middle of the hereditary medicines arms race, Flagship Pioneering is actually unveiling a br...

BioAge eyes $180M coming from IPO, personal placement for excessive weight tests

.BioAge Labs is eyeing around $180 thousand in first earnings coming from an IPO and an exclusive po...

Merck's LAG-3 combo neglects colon cancer period 3 study

.An effort by Merck &amp Co. to unlock the microsatellite secure (MSS) metastatic colon cancer cells...

Spanish VC closes $200M life sciences fund

.Spain-based Asabys Partners has actually closed a fund of 180 thousand europeans ($ 200 thousand), ...

BioAge produces $198M from IPO as obesity biotech participates in Nasdaq

.BioAge Labs is actually bringing in just about $200 thousand using its Nasdaq IPO today, with the p...